Our Janssen Promise At Janssen, we’re creating a future where disease is About a thing of the past. THERAPEUTIC DOMAINS Janssen

IMMUNOLOGY ONCOLOGY NEUROSCIENCE At Janssen, we're creating a future where disease is a thing of the past.

We’re the Pharmaceutical

INFECTIOUS DISEASES CARDIOVASCULAR & PULMONARY Companies of Johnson & Johnson, & VACCINES METABOLISM HYPERTENSION working tirelessly to make that future a reality for patients everywhere by fighting sickness Janssen with science, improving access with ingenuity, and healing hopelessness with heart. FACTS &

We focus on areas of medicine FIGURES where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, SITES Neuroscience, Oncology, and Pulmonary Hypertension. 6 Olen Merksem La Louvière

Janssen is the pharmaceutical sector of Johnson & Johnson. Johnson & Johnson is made up of three sectors:

Pharma (Janssen) | Consumer | Medical Devices © Janssen-Cilag NV - EM-24175- 29-nov-2019 - vu/er Vincent Seynhaeve, Antwerpseweg 2340 15-17, Beerse +5.050 EMPLOYEES TOP 10 MOST ATTRACTIVE 46% 54% private employer GREEN ENERGY Janssen Pharmaceutics is the only company in Belgium that has By 2050, we want to be +60 always managed to score in the top ten of the survey into the most attractive employer since it began (2000).** completely CO2 neutral. This will be achieved NATIONALITIES JANSSEN FACTS & FIGURES using our deep geothermal power plant in combination with our unique heat network. In 2018 we invested The final system will be ready for use in 2021. BILLION EURO We are the first - and so far the only - private IN R&D company in Belgium to use this concept on 1,530 this scale for its own energy supply.

INVESTMENTS IN BELGIUM FROM LAB TO PATIENT By investing in innovation and the optimization of our Janssen in Belgium is responsible for the entire production process, production processes, we are ready for the challenges of In 2018, Janssen conducted tomorrow. Some examples of this are the optimization of from early-stage development to our supply chain, the continuous production line and the CLINICAL STUDIES commercialization. Labs In One Network (LION) project, a high-tech laboratory 113 in Belgium. environment. ON 1 CAMPUS Janssen Research and Development

NEW MEDICINES Janssen Supply Chain 18 launched worldwide since 2011. Janssen commercial departments 18 MEDICINES Our worldwide investments in R&D RANGE AMONG on the List of Essential Medicines of the WHO THE HIGHEST in the pharmaceutical industry.* (World Health Organization).

Internal data Janssen, status 2018. *PricewaterHouseCoopers. 2018 Global Innovation 1000 Study. /janssenbelgium /janssenBelgium /janssen-belgium **Source: Randstad.